The Company discovers, develops, manufactures and sells products in one of its business segment of pharmaceutical products to prevent and treat human diseases.


Updates from The Motley Fool

Latest updates on Eli Lilly and Company from Fool.com.  The Fool has written over 800 articles on Eli Lilly and Company.
2016's Worst Clinical Failures

It's been a rough year for drugmakers, but late clinical-stage failures made it especially tough ...

Why Eli Lilly Is Cratering Today

Shares fall by double digits in response to disappointing news from an important clinical trial.



Stock Performance

View Interactive LLY Charts
Sponsored by

Key Data Points

Primary metrics and data points about Eli Lilly and Company.
Current Price: $77.96
Prev Close: $77.99
Open: $77.99
Bid: $76.36
Ask: $78.50
Day's Range: $77.80 - $78.28
52wk Range: $64.18 - $86.72
Volume: 2,254,384
Avg Vol 4,519,903
Market Cap: $86B
P/E (ttm): 37.68
EPS (ttm): $2.07
Div & Yield: $2.08 (2.7%)

Company Rating

What our community thinks about Eli Lilly and Company.
CAPS Rating 4 out of 5
 
1222 Outperform
103 Underperform
CAPS All Stars
 
327 Outperform
18 Underperform

How do you think Eli Lilly and Company will perform against the market?



You pick for Eli Lilly and Company is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

John C. Lechleiter, CEO

90% Approve

Based on 636 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Eli Lilly and Company.

The Company discovers, develops, manufactures and sells products in one of its business segment of pharmaceutical products to prevent and treat human diseases.

  • Exchange: NYSE
  • Sector: Healthcare
  • Industry: Drug Makers